Silo Wellness Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SILFF research report →
Companywww.silowellness.com
Silo Wellness Inc. , a psychedelics and wellness company, develops psychedelic medicine to reduce trauma. It develops and sells psilocybin-free functional mushroom tinctures; and the formulation of a psilocybin nasal spray in Jamaica.
- CEO
- Mike Arnold
- IPO
- 2021
- HQ
- Toronto, ON, CA
Price Chart
Valuation
- Market Cap
- $1.73M
- P/E
- -0.09
- P/S
- 3.34
- P/B
- -0.10
- EV/EBITDA
- -0.23
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 36.62%
- Op Margin
- -1491.09%
- Net Margin
- -1730.85%
- ROE
- 205.27%
- ROIC
- 95.00%
Growth & Income
- Revenue
- $335.81K · 179.56%
- Net Income
- $-5,812,400 · 6.39%
- EPS
- $-0.16 · 96.00%
- Op Income
- $-5,007,242
- FCF YoY
- 86.18%
Performance & Tape
- 52W High
- $0.01
- 52W Low
- $0.01
- 50D MA
- $0.01
- 200D MA
- $0.01
- Beta
- 0.77
- Avg Volume
- 0
Get TickerSpark's AI analysis on SILFF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our SILFF Coverage
We haven't published any research on SILFF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate SILFF Report →